NCT06208137View on ClinicalTrials.gov

Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.

NARecruitingINTERVENTIONAL
Enrollment

456

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

October 1, 2027

Study Completion Date

April 1, 2028

Conditions
Transplant-Related Disorder
Interventions
BEHAVIORAL

Health monitoring and regular return follow-up reminders

Health monitoring \& reminders for blood tests and follow-up visits until 1 year post-transplant

Trial Locations (1)

300020

RECRUITING

Institute of Hematology & Blood Diseases Hospital, Tianjin

All Listed Sponsors
lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER